PMV Pharmaceuticals, Inc. (PMVP) stock
PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.88−0.43 (-33.13%)
Close on Nov 20, 2026Market cap $46.83MP/E –Yield –
PMV Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
PMV Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$71.28M. For fiscal 2025 it was -$73.61M. The highest annual figure on record is -$15.63M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$73.61M | – |
| FY2024 | Dec 31, 2024 | -$51.94M | – |
| FY2023 | Dec 31, 2023 | -$56.62M | – |
| FY2022 | Dec 31, 2022 | -$71.74M | – |
| FY2021 | Dec 31, 2021 | -$47.92M | – |
| FY2020 | Dec 31, 2020 | -$32.89M | – |
| FY2019 | Dec 31, 2019 | -$22.17M | – |
| FY2018 | Dec 31, 2018 | -$15.63M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.58M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.68M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.20M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$18.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.27M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.72M | – |
| Q3 FY2024 | Sep 30, 2024 | -$16.84M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.60M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.78M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.70M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.47M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.17M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.96M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.81M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.18M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.79M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.29M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.90M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.71M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.02M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.37M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.43M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.90M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.19M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.13M | – |
See a number that looks wrong?